Product image of Inteb (Budesonide) supplied by GNH India

Inteb

Active Ingredient:
Budesonide
Origin:
EU

Inteb (Budesonide)

Budesonide, the active ingredient in Inteb, is a corticosteroid presented as an oral formulation for systemic use. It exerts anti‑inflammatory effects by binding glucocorticoid receptors, thereby decreasing cytokine production and immune cell activation. Clinically, it is indicated for the management of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, aiming to induce and maintain remission in adult patients.

GNH India supplies Inteb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality through stringent manufacturing and regulatory standards.

Manufacturer / TM Owner

S.F. Group Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Budesonide (Inteb) is used in inflammatory bowel disease management to control mucosal inflammation.

  • Crohn's disease: reduces intestinal inflammation and assists in inducing remission.
  • Ulcerative colitis: diminishes colonic inflammation and supports remission induction.
  • Maintenance of Crohn's disease remission: helps sustain disease control after induction.
  • Maintenance of ulcerative colitis remission: aids in preventing relapse after initial therapy.

How It Works

  • Budesonide acts as a glucocorticoid receptor agonist. After oral absorption, it binds intracellular glucocorticoid receptors, translocates to the nucleus, and modulates gene transcription. This results in inhibition of pro‑inflammatory cytokine production, reduced activation of immune cells, and suppression of inflammatory pathways within the gastrointestinal mucosa, leading to decreased inflammation.

Side Effects

Budesonide may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal upset.
  • Abdominal pain: discomfort in the stomach area.
  • Upper respiratory tract infection: mild cold‑like symptoms.
  • Oral candidiasis: fungal infection of the mouth.
  • Increased blood glucose: transient rise in glucose levels.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production.
  • Severe infection: heightened risk of bacterial or fungal infections.
  • Osteoporosis: decreased bone mineral density with long‑term use.
  • Cushing's syndrome: signs of excess glucocorticoid exposure.
  • Hypersensitivity reactions: rash, angioedema, or anaphylaxis.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

  • Monitor adrenal function: assess for signs of insufficiency during and after treatment.
  • Assess infection risk: avoid use in patients with active systemic infections.
  • Use caution in hepatic impairment: dose adjustments may be required.
  • Do not discontinue abruptly: taper the dose to prevent withdrawal.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Budesonide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure and risk of adverse effects.
  • Live vaccines: immunosuppression can reduce vaccine efficacy and increase infection risk.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (warfarin): budesonide may enhance anticoagulant effect, requiring INR monitoring.
  • Antidiabetic agents: glucocorticoid effect may raise blood glucose, necessitating dose adjustments.
  • CYP3A4 inducers (e.g., rifampin): may reduce budesonide concentrations and diminish therapeutic effect.

Frequently Asked Questions

Inteb, containing budesonide, is prescribed for the treatment of inflammatory bowel diseases, specifically Crohn's disease and ulcerative colitis. It helps reduce intestinal inflammation, facilitating induction of remission and, in some regimens, maintenance of disease control in adult patients.

Budesonide binds to glucocorticoid receptors inside cells, altering gene transcription. This suppresses the production of pro‑inflammatory cytokines and limits activation of immune cells in the gut mucosa, thereby decreasing inflammation and promoting healing of the intestinal lining.

The dose of Inteb is individualized by the prescribing clinician based on disease severity, patient weight, and response to therapy. Healthcare providers determine the appropriate strength, frequency, and duration according to current clinical guidelines and patient-specific factors.

Safety of budesonide during pregnancy or lactation should be evaluated by a healthcare professional. While systemic exposure is lower than with some steroids, the prescriber will weigh potential benefits against any risks to the fetus or infant before recommending use.

To place an order, submit an enquiry on the Inteb product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with conventional systemic steroids, budesonide has a high first‑pass metabolism, resulting in lower systemic exposure and a reduced risk of classic steroid‑related side effects. This makes it a preferred option for mild to moderate IBD when localized anti‑inflammatory action is desired.

Inteb should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Inteb is taken orally, usually with water. The exact dosing schedule—such as once or twice daily—and whether it should be taken with food are determined by the prescribing physician based on the individual treatment plan.

Serious risks include adrenal suppression, severe infections, osteoporosis with long‑term use, and rare occurrences of Cushing's syndrome or hypersensitivity reactions. Patients should be monitored regularly for signs of these complications, especially during prolonged therapy.

Inteb is contraindicated in patients with known hypersensitivity to budesonide or any formulation excipients, those with active systemic infections, and individuals for whom systemic corticosteroid therapy is contraindicated. Clinicians should also exercise caution in patients with uncontrolled diabetes, severe hepatic impairment, or a history of osteoporosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Budesonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT